Explore the latest news
Dive deeper to find out what we’re up to locally and around the globe.
July 18, 2023
Two grants will help fund TB and HPV test completion.
July 13, 2023
Funding will target upper respiratory panel development.
January 14, 2023
Generating widespread interest and coast-to-coast coverage.
November 15, 2022
Six women wage war on COVID, making over 20,000 RT-PCR tests.
November 15, 2022
Highlighting in vitro diagnostic and research products.
March 24, 2022
Achievement attributed to sales of Co-Dx Logix Smart™ Covid-19 test.
January 3, 2022
Finalizing agreements with Idaho Molecular and Advanced Conceptions.
May 24, 2021
Highlighting the importance of getting vaccines to everyone who needs them.
November 10, 2020
The power of Co-Primers™ in an easy-to-collect sample type.
June 5, 2020
Co-Dx and TestUtah evaluate a lower rate of positives than the state average.
December 26, 2013
Featured in the Journal of Molecular Diagnostics.
March 3, 2025
On January 14, 2025, CEO Dwight Egan sat down with Nasdaq Listings host Kristina Ayanian at the Silicon Slopes Summit
February 24, 2025
On February 4, 2025, Co-Dx joint venture CoSara Diagnostics Pvt. Ltd. hosted a Holistic Cancer Awareness lecture series in observance
December 16, 2024
Co-Dx and our Indian joint venture, CoSara Diagnostics Pvt. Ltd, inaugurated the oligonucleotide synthesis facility in Ranoli, India on December
November 27, 2024
Tuberculosis has a complicated history as an endemic killer for thousands of years, with infection rates continuing to rise regardless
September 11, 2024
Experts worry climate change is driving mosquito populations into new regions while lengthening active mosquito seasons, leading to an expansion
August 22, 2024
Co-Dx discussed the advancement of POC/OTC diagnostics on July 30-August 1 at ADLM 2024 in Chicago, Il
